Takeshita A - Search Results

1

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.

Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H. Fukumoto Y, et al. Among authors: takeshita a. Heart. 2005 Mar;91(3):391-2. doi: 10.1136/hrt.2003.029470. Heart. 2005. PMID: 15710736 Free PMC article. No abstract available.

2

[Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].

Hiroki J, Fukumoto Y, Shimokawa H, Hirooka Y, Takeshita A. Hiroki J, et al. Among authors: takeshita a. J Cardiol. 2004 Oct;44(4):161-4. J Cardiol. 2004. PMID: 15532247 Japanese.

3

Rho-kinase is an important therapeutic target in cardiovascular medicine.

Shimokawa H, Takeshita A. Shimokawa H, et al. Among authors: takeshita a. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1767-75. doi: 10.1161/01.ATV.0000176193.83629.c8. Epub 2005 Jul 7. Arterioscler Thromb Vasc Biol. 2005. PMID: 16002741 Review.

4

Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.

Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H. Fukumoto Y, et al. Among authors: takeshita a. J Cardiovasc Pharmacol. 2007 Mar;49(3):117-21. doi: 10.1097/FJC.0b013e31802ef532. J Cardiovasc Pharmacol. 2007. PMID: 17414222 Clinical Trial.

5

Rho-kinase, a potential therapeutic target for the treatment of hypertension.

Hirooka Y, Shimokawa H, Takeshita A. Hirooka Y, et al. Among authors: takeshita a. Drug News Perspect. 2004 Oct;17(8):523-7. doi: 10.1358/dnp.2004.17.8.863696. Drug News Perspect. 2004. PMID: 15605112 Review.

6

Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.

Kishi T, Hirooka Y, Masumoto A, Ito K, Kimura Y, Inokuchi K, Tagawa T, Shimokawa H, Takeshita A, Sunagawa K. Kishi T, et al. Among authors: takeshita a. Circulation. 2005 May 31;111(21):2741-7. doi: 10.1161/CIRCULATIONAHA.104.510248. Circulation. 2005. PMID: 15927989 Clinical Trial.

7

Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.

Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, Takeshita A. Mukai Y, et al. Among authors: takeshita a. FASEB J. 2001 Apr;15(6):1062-4. doi: 10.1096/fj.00-0735fje. FASEB J. 2001. PMID: 11292668 No abstract available.

8

Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.

Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Mohri M, et al. Among authors: takeshita a. J Am Coll Cardiol. 2003 Jan 1;41(1):15-9. doi: 10.1016/s0735-1097(02)02632-3. J Am Coll Cardiol. 2003. PMID: 12570938 Free article. Clinical Trial.

9

Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition.

Ito K, Hirooka Y, Kishi T, Kimura Y, Kaibuchi K, Shimokawa H, Takeshita A. Ito K, et al. Among authors: takeshita a. Hypertension. 2004 Feb;43(2):156-62. doi: 10.1161/01.HYP.0000114602.82140.a4. Epub 2004 Jan 19. Hypertension. 2004. PMID: 14732730

10

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans.

Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Masumoto A, et al. Among authors: takeshita a. Hypertension. 2001 Dec 1;38(6):1307-10. doi: 10.1161/hy1201.096541. Hypertension. 2001. PMID: 11751708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,026 results

Search Page

Filters